> Medic inal products that affect coagulation or those that alter platelet function (e.g. TICLOPIDINE, CLOPIDOGREL, LMWH) may increase the risk of bleeding prior to, during or after tenecteplase therapy.Concomitant use of GPIIb/IIIa antagonists increases bleedin g risk.6
